Tan Kevin
- SEC CIK
- 0001884056
In the past year, 4 open-market sale filings worth $329.5K and no purchases.
Current role at each company
- SLDB Solid Biosciences Inc.CFO & Treasureras of Apr 21, 2026
- RNAC Cartesian Therapeutics, Inc.Chief Financial Officeras of Jan 5, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $329.5K
- 4 filings
- Net
- −$329.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Tan Kevin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SLDB Solid Biosciences Inc.
CFO & Treasurer7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 (view filing) | Feb 18 | Same day | Tan KevinCFO & Treasurer | SSale | −5.40K | $5.82 | −$31.5K | −5.2%99.4K after | 10b5-1 |
| Feb 6, 2026 (view filing) | Feb 4 | 2 days | Tan KevinCFO & Treasurer | SSale | −14.8K | $6.44 | −$95.2K | −13.6%94.2K after | 10b5-1 |
| Feb 2, 2026 (view filing) | Feb 2 | Same day | Tan KevinCFO & Treasurer | SSale | −26.8K | $6.44 | −$172.8K | −19.8%109.0K after | 10b5-1 |
| Jan 13, 2026 (view filing) | Jan 13 | Same day | Tan KevinCFO & Treasurer | SSale | −5.70K | $5.27 | −$30.1K | −11.0%46.1K after | 10b5-1 |
| Feb 18, 2025 (view filing) | Feb 14 | 4 days | Tan KevinCFO & Treasurer | SSale | −3.16K | $3.96 | −$12.5K | −8.9%32.3K after | 10b5-1 |
| Jan 13, 2025 (view filing) | Jan 10 | 3 days | Tan KevinCFO & Treasurer | SSale | −4.07K | $3.89 | −$15.8K | −14.1%24.8K after | |
| Jan 11, 2024 (view filing) | Jan 9 | 2 days | Tan KevinCFO & Treasurer | SSale | −3.94K | $8.20 | −$32.3K | −29.7%9.31K after |
RNAC Cartesian Therapeutics, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2021 (view filing) | Dec 2 | 4 days | Tan KevinChief Financial Officer | PPurchase | +5.00K | $3.03 | +$15.2K | New position5.00K after |